SEC Form 4 · accession 0001209191-18-036089
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Vachon
Director
Period of report
Jun 4, 2018
Accepted (ET)
Jun 6, 2018 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 4, 2018 | M | 2,000 | $30.47 | A | 3,000 | D | |
| Common Stock | Jun 4, 2018 | M | 4,000 | $47.87 | A | 7,000 | D | |
| Common StockF2 | Jun 4, 2018 | S | 3,000 | $186.487 | D | 4,000 | D | |
| Common StockF3 | Jun 4, 2018 | S | 500 | $187.28 | D | 3,500 | D | |
| Common StockF4 | Jun 4, 2018 | S | 300 | $188.4767 | D | 3,200 | D | |
| Common StockF5 | Jun 4, 2018 | S | 1,000 | $190.145 | D | 2,200 | D | |
| Common StockF6 | Jun 4, 2018 | S | 700 | $190.9321 | D | 1,500 | D | |
| Common StockF7 | Jun 4, 2018 | S | 500 | $191.72 | D | 1,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF8 | $30.47 | Jun 4, 2018 | M | 2,000 | D | — | Jul 16, 2024 | Common Stock | 2,000 | 0 | D |
| Stock Option | $47.87 | Jun 4, 2018 | M | 4,000 | D | Jun 2, 2017 | Jun 2, 2026 | Common Stock | 4,000 | 0 | D |
Explanation of responses
- F1The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2017.
- F2The range in prices for the transaction reported on this line was $186.00 to $186.90. The average weighted price was $186.4870. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range in prices for the transaction reported on this line was $187.05 to $187.45. The average weighted price was $187.28. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range of prices for the transaction reported on this line was $188.10 to $188.95. The average weighted price was $188.4767. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range of prices for the transaction reported on this line was $189.45 to $190.40. The average weighted price was $190.145. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The range of prices for the transaction reported on this line was $190.50 to $191.15. The average weighted price was $190.9321. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7The range of prices for the transaction reported on this line was $191.55 to $192.00. The average weighted price was $191.72. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F8This option vests ratably over three years in annual installments, commencing on July 16, 2015.